But even with promising data, it remains a research-stage option, not a standard clinic treatment
Nat Med
The study utilized a single-blind, randomized, placebo-controlled, crossover design, combined with functional magnetic resonance imaging (fMRI), to analyze the performance of 54 participants (30 with normal insulin sensitivity and 24 with impaired insulin sensitivity) on sensory associative learning tasks while receiving liraglutide and placebo treatments
However, under the Medicare GLP-1 Bridge program announced by CMS in December 2025, eligible Medicare Part D beneficiaries will be able to access Foundayo beginning July 1, 2026, for approximately $50 per month
The early data from obesity trials shows favorable trends in cardiovascular risk factors, but definitive outcome data remains forthcoming